Durable polymers used for first-generation drug-eluting stents (DES) potentially contribute to persistent
inflammation and late DES thrombosis. We report the first in human experience with the rapamycin-eluting biodegradable polymer coated cobalt-chromium FIREHAWK® stent with abluminal groove. ...


